When you think you're getting skincare from a great brand but it's actually made in an industrial park in Louisiana, near a National Tire Wholesale and a Safelite AutoGlass...
and it's contaminated with high levels of cancer-causing benzene to boot
The No Surprises Act was supposed to end surprise medical bills. It succeeded. But the law also accidentally created a system that has enriched medical providers, middlemen and arbitration firms. @sarahkliff
Hormone therapy is making a $6 billion comeback after U.S. health officials nixed safety warnings that kept women from much-needed menopause and perimenopause treatments for two decades
Baby formula recalls rocking companies in Europe and the US have exposed a weakness in an industry that has been increasingly trying to fashion itself as more and more like breast milk: The more sophisticated it tries to be, the harder it is to keep safe
bloomberg.com/news/features/…
In my @business Big Take out today I explored how Hologic pushed a medical device on breast cancer patients despite hundreds of complaints, most of which stayed buried until now
Mary Munney Griffiths' breast surgeon pulled 24 shards of plastic out of her chest after the device broke apart inside her, leaving her in constant pain
Important and disturbing story reported by @annaedney@tanaz115 in @business about BioZorb's breast implant device -- another example of the harms sustained by patients under our outdated system for postmarket device surveillance:
bloomberg.com/features/2025-…
A small medical device was supposed to transform breast cancer care. The FDA approved it without clinical trials or even proof it would work.
Then, when complaints from women tormented by the device began flowing in, they were hidden for years…until now
bloomberg.com/features/2025-…
Would you take a medicine made at a factory that was so bad the FDA banned it from shipping drugs here?
You might have already.
@propublica uncovered how for years the FDA has quietly let these risky drugs into hospitals and medicine cabinets
propublica.org/article/fda-d…